Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Implementing the European Renal Best Practice Guidelines suggests that prediction equations work well to differentiate risk of end-stage renal disease vs. death in older patients with low estimated glomerular filtration rate.

Hallan SI, Rifkin DE, Potok OA, Katz R, Langlo KA, Bansal N, Ix JH.

Kidney Int. 2019 May 10. pii: S0085-2538(19)30484-3. doi: 10.1016/j.kint.2019.04.022. [Epub ahead of print]

PMID:
31301887
2.

Gene Expression Studies and Targeted Metabolomics Reveal Disturbed Serine, Methionine, and Tyrosine Metabolism in Early Hypertensive Nephrosclerosis.

Øvrehus MA, Bruheim P, Ju W, Zelnick LR, Langlo KA, Sharma K, de Boer IH, Hallan SI.

Kidney Int Rep. 2018 Oct 17;4(2):321-333. doi: 10.1016/j.ekir.2018.10.007. eCollection 2019 Feb.

3.

Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium.

Chang AR, Grams ME, Ballew SH, Bilo H, Correa A, Evans M, Gutierrez OM, Hosseinpanah F, Iseki K, Kenealy T, Klein B, Kronenberg F, Lee BJ, Li Y, Miura K, Navaneethan SD, Roderick PJ, Valdivielso JM, Visseren FLJ, Zhang L, Gansevoort RT, Hallan SI, Levey AS, Matsushita K, Shalev V, Woodward M; CKD Prognosis Consortium (CKD-PC).

BMJ. 2019 Jan 10;364:k5301. doi: 10.1136/bmj.k5301.

4.

Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium.

Inker LA, Grams ME, Levey AS, Coresh J, Cirillo M, Collins JF, Gansevoort RT, Gutierrez OM, Hamano T, Heine GH, Ishikawa S, Jee SH, Kronenberg F, Landray MJ, Miura K, Nadkarni GN, Peralta CA, Rothenbacher D, Schaeffner E, Sedaghat S, Shlipak MG, Zhang L, van Zuilen AD, Hallan SI, Kovesdy CP, Woodward M, Levin A; CKD Prognosis Consortium.

Am J Kidney Dis. 2019 Feb;73(2):206-217. doi: 10.1053/j.ajkd.2018.08.013. Epub 2018 Oct 19.

PMID:
30348535
5.

Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis.

Kovesdy CP, Matsushita K, Sang Y, Brunskill NJ, Carrero JJ, Chodick G, Hasegawa T, Heerspink HL, Hirayama A, Landman GWD, Levin A, Nitsch D, Wheeler DC, Coresh J, Hallan SI, Shalev V, Grams ME; CKD Prognosis Consortium .

Eur Heart J. 2018 May 1;39(17):1535-1542. doi: 10.1093/eurheartj/ehy100.

6.

The Possibilities to Improve Kidney Health with Proteomics.

Hallan SI.

Clin J Am Soc Nephrol. 2017 Jul 21. pii: CJN.06200617. doi: 10.2215/CJN.06200617. [Epub ahead of print] No abstract available.

7.

Long-term changes in albuminuria: underlying causes and future mortality risk in a 20-year prospective cohort: the Nord-Trøndelag Health (HUNT) Study.

Romundstad S, Hatlen G, Hallan SI.

J Hypertens. 2016 Oct;34(10):2081-9. doi: 10.1097/HJH.0000000000001035.

PMID:
27442788
8.

Long-term trends in the prevalence of chronic kidney disease and the influence of cardiovascular risk factors in Norway.

Hallan SI, Øvrehus MA, Romundstad S, Rifkin D, Langhammer A, Stevens PE, Ix JH.

Kidney Int. 2016 Sep;90(3):665-73. doi: 10.1016/j.kint.2016.04.012. Epub 2016 Jun 22.

PMID:
27344204
9.

Influence of Gender and Repeated Urine Sampling on the Association of Albuminuria with Coronary Events.

Hatlen G, Romundstad S, Salvesen Ø, Dalen H, Hallan SI.

Nephron. 2016;133(1):44-52. doi: 10.1159/000445856. Epub 2016 Apr 30.

PMID:
27161102
10.

Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis.

Tangri N, Grams ME, Levey AS, Coresh J, Appel LJ, Astor BC, Chodick G, Collins AJ, Djurdjev O, Elley CR, Evans M, Garg AX, Hallan SI, Inker LA, Ito S, Jee SH, Kovesdy CP, Kronenberg F, Heerspink HJ, Marks A, Nadkarni GN, Navaneethan SD, Nelson RG, Titze S, Sarnak MJ, Stengel B, Woodward M, Iseki K; CKD Prognosis Consortium.

JAMA. 2016 Jan 12;315(2):164-74. doi: 10.1001/jama.2015.18202. Erratum in: JAMA. 2016 Feb 23;315(8):822.

11.

Urinary proteomics in chronic kidney disease: diagnosis and risk of progression beyond albuminuria.

Øvrehus MA, Zürbig P, Vikse BE, Hallan SI.

Clin Proteomics. 2015 Aug 7;12(1):21. doi: 10.1186/s12014-015-9092-7. eCollection 2015.

12.

Cardiovascular disease prevention in CKD.

Hallan SI.

Am J Kidney Dis. 2014 Sep;64(3):326-8. doi: 10.1053/j.ajkd.2014.06.005. No abstract available.

PMID:
25150852
13.

The accuracy of predicting cardiovascular death based on one compared to several albuminuria values.

Hatlen G, Romundstad S, Hallan SI.

Kidney Int. 2014 Jun;85(6):1421-8. doi: 10.1038/ki.2013.500. Epub 2013 Dec 18.

14.

Moderator's view: Estimating glomerular filtration rate--the past, present and future.

Hallan SI, Gansevoort RT.

Nephrol Dial Transplant. 2013 Jun;28(6):1404-6. doi: 10.1093/ndt/gfs607. No abstract available.

PMID:
23780678
15.

Measures to define chronic kidney disease--reply.

Hallan SI, Matsushita K, Coresh J; Chronic Kidney Disease Prognosis Consortium.

JAMA. 2013 Apr 3;309(13):1343-4. doi: 10.1001/jama.2013.1349. No abstract available.

PMID:
23549570
16.

Age and association of kidney measures with mortality and end-stage renal disease.

Hallan SI, Matsushita K, Sang Y, Mahmoodi BK, Black C, Ishani A, Kleefstra N, Naimark D, Roderick P, Tonelli M, Wetzels JF, Astor BC, Gansevoort RT, Levin A, Wen CP, Coresh J; Chronic Kidney Disease Prognosis Consortium.

JAMA. 2012 Dec 12;308(22):2349-60.

17.

Association of mild to moderate chronic kidney disease with venous thromboembolism: pooled analysis of five prospective general population cohorts.

Mahmoodi BK, Gansevoort RT, Næss IA, Lutsey PL, Brækkan SK, Veeger NJ, Brodin EE, Meijer K, Sang Y, Matsushita K, Hallan SI, Hammerstrøm J, Cannegieter SC, Astor BC, Coresh J, Folsom AR, Hansen JB, Cushman M.

Circulation. 2012 Oct 16;126(16):1964-71. doi: 10.1161/CIRCULATIONAHA.112.113944. Epub 2012 Sep 13.

18.

Smoking is a risk factor in the progression to kidney failure.

Hallan SI, Orth SR.

Kidney Int. 2011 Sep;80(5):516-23. doi: 10.1038/ki.2011.157. Epub 2011 Jun 15.

19.

Kidney function for the non-nephrologist: an emerging tool for predicting mortality risk.

Hallan SI.

Kidney Int. 2011 Jan;79(1):8-10. doi: 10.1038/ki.2010.362.

20.

The conundrum of chronic kidney disease classification and end-stage renal risk prediction in the elderly--what is the right approach?

Hallan SI, Orth SR.

Nephron Clin Pract. 2010;116(4):c307-16. doi: 10.1159/000319166. Epub 2010 Jul 24. Review.

21.

The KDOQI 2002 classification of chronic kidney disease: for whom the bell tolls.

Hallan SI, Orth SR.

Nephrol Dial Transplant. 2010 Sep;25(9):2832-6. doi: 10.1093/ndt/gfq370. Epub 2010 Jul 1. No abstract available.

PMID:
20601368
22.

Use of a prostate symptom score to identify men at risk of future kidney failure: insights from the HUNT II Study.

Hallan SI, Kwong D, Vikse BE, Stevens P.

Am J Kidney Dis. 2010 Sep;56(3):477-85. doi: 10.1053/j.ajkd.2010.03.021. Epub 2010 Jun 11.

PMID:
20541300
23.

[Complementation of eGFR by urinary albumin excretion - the way to a new classification system of chronic kidney disease].

Orth SR, Hallan SI.

Dtsch Med Wochenschr. 2010 Jun;135(24):1241-6. doi: 10.1055/s-0030-1255144. Epub 2010 Jun 8. Review. German. No abstract available.

PMID:
20533159
24.

Screening for chronic kidney disease: which strategy?

Hallan SI, Stevens P.

J Nephrol. 2010 Mar-Apr;23(2):147-55. Review.

PMID:
20155721
25.
26.

Intrauterine growth restriction: no unifying risk factor for the metabolic syndrome in young adults.

Euser AM, Dekker FW, Hallan SI.

Eur J Cardiovasc Prev Rehabil. 2010 Jun;17(3):314-20. doi: 10.1097/HJR.0b013e328331d2c3.

PMID:
19773661
27.

Chronic kidney disease: a new opportunity for better cardiovascular risk stratification.

Hallan SI.

J Intern Med. 2009 Oct;266(4):414-7. doi: 10.1111/j.1365-2796.2009.02147.x. No abstract available.

28.

Combining GFR and albuminuria to classify CKD improves prediction of ESRD.

Hallan SI, Ritz E, Lydersen S, Romundstad S, Kvenild K, Orth SR.

J Am Soc Nephrol. 2009 May;20(5):1069-77. doi: 10.1681/ASN.2008070730. Epub 2009 Apr 8.

29.

Relationship between chronic kidney disease prevalence and end-stage renal disease risk.

Hallan SI, Vikse BE.

Curr Opin Nephrol Hypertens. 2008 May;17(3):286-91. doi: 10.1097/MNH.0b013e3282f8b177. Review.

PMID:
18408480
30.

Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population.

Astor BC, Hallan SI, Miller ER 3rd, Yeung E, Coresh J.

Am J Epidemiol. 2008 May 15;167(10):1226-34. doi: 10.1093/aje/kwn033. Epub 2008 Apr 2.

PMID:
18385206
32.

Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey.

Hallan SI, Dahl K, Oien CM, Grootendorst DC, Aasberg A, Holmen J, Dekker FW.

BMJ. 2006 Nov 18;333(7577):1047. Epub 2006 Oct 24.

33.

International comparison of the relationship of chronic kidney disease prevalence and ESRD risk.

Hallan SI, Coresh J, Astor BC, Asberg A, Powe NR, Romundstad S, Hallan HA, Lydersen S, Holmen J.

J Am Soc Nephrol. 2006 Aug;17(8):2275-84. Epub 2006 Jun 21.

Supplemental Content

Loading ...
Support Center